{
  "ticker": "AMPH",
  "company_name": "Amphastar Pharmaceuticals, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01174732",
      "title": "Dose-Ranging Study of A006 DPI, in Adult Asthma Patients",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Asthma, Bronchospasm",
      "start_date": "2010-07",
      "completion_date": "2011-01",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT01025648",
      "title": "Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Asthma",
      "start_date": "2009-12",
      "completion_date": "2009-12",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT02271334",
      "title": "Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Asthma",
      "start_date": "2014-08",
      "completion_date": "2015-03",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT00634517",
      "title": "4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Asthma",
      "start_date": "2008-03",
      "completion_date": "2008-12",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT01255709",
      "title": "Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Asthma",
      "start_date": "2010-12",
      "completion_date": "2011-01",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT00634829",
      "title": "Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Asthma, Bronchospasm",
      "start_date": "2008-02",
      "completion_date": "2008-10",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT01737892",
      "title": "Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Asthma",
      "start_date": "2012-11",
      "completion_date": "2012-11",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT02210806",
      "title": "Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Asthma",
      "start_date": "2014-07",
      "completion_date": "2014-10",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT00635505",
      "title": "Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Asthma",
      "start_date": "2007-09",
      "completion_date": "2008-08",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    },
    {
      "nct_id": "NCT01581177",
      "title": "Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Asthma",
      "start_date": "2012-04",
      "completion_date": "2012-08",
      "enrollment": 0,
      "sponsor": "Amphastar Pharmaceuticals, Inc."
    }
  ],
  "summary": {
    "total_trials": 20,
    "by_phase": {
      "PHASE2": 7,
      "PHASE1, PHASE2": 4,
      "PHASE3": 7,
      "PHASE4": 1,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 15,
      "TERMINATED": 5
    },
    "active_trials": 0,
    "completed_trials": 15,
    "conditions": [
      "Allergic Skin Reaction",
      "Asthma",
      "Asthma, Bronchospasm",
      "Asthma, Bronchospasm, Chronic Obstructive Pulmonary Disease (COPD)",
      "Asthma, Bronchospasm, Wheezing, Shortness of Breath",
      "Pharmacokinetics, Epinephrine, Albuterol, Asthma, Anaphylaxis",
      "Pharmacokinetics, Pharmacodynamics"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:20.066692",
    "search_query": "Amphastar Pharmaceuticals, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Amphastar+Pharmaceuticals,+Inc."
  }
}